What is the best course of action for a 56-year-old female with a history of anxiety, gout, and depression, currently taking Duloxetine, Bupropion, Gabapentin, Cymbalta (Duloxetine), and Buspar (Buspirone), who reports a slight increase in anxiety due to life situations and requests a dose increase of Buspar?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 11, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

I recommend increasing the Buspar (buspirone) dosage to 15-20 mg daily in divided doses to address the patient's increased anxiety while maintaining her current Cymbalta (duloxetine) dose. The patient is already on multiple psychotropic medications, including duloxetine, bupropion, and gabapentin, so it's essential to monitor her closely for potential interactions or side effects. According to the guidelines for managing behavior and mood disorders 1, buspirone is a suitable option for managing mild to moderate anxiety, and its dosage can be increased up to 20 mg three times daily.

Before implementing this change, it's crucial to review her current Buspar dosage and schedule to ensure the increase stays within safe therapeutic ranges. The patient should be informed that buspirone may take 2-4 weeks to become effective, as stated in the guidelines 1. A follow-up appointment in 3-4 weeks would be appropriate to assess the effectiveness of the increased dosage and monitor for potential side effects such as dizziness, headache, or nausea.

The patient's decision to decline imaging for her resolved clavicle pain is reasonable since it's no longer causing concern, and no other medical issues require immediate attention. However, it's essential to continue monitoring her overall mental health and adjust her treatment plan as needed to ensure optimal management of her anxiety, depression, and other conditions.

Key considerations for the patient's treatment plan include:

  • Monitoring for potential interactions between buspirone and other psychotropic medications
  • Regular follow-up appointments to assess the effectiveness of the treatment plan and adjust as needed
  • Patient education on the potential side effects of buspirone and the importance of reporting any concerns or changes in her condition.

From the FDA Drug Label

The concomitant use of buspirone with MAOIs intended to treat depression is contraindicated. Buspirone should also not be started in a patient who is being treated with reversible MAOIs such as linezolid or intravenous methylene blue The administration of buspirone hydrochloride tablets to a patient taking a monoamine oxidase inhibitor (MAOI) may pose a hazard.

The patient is taking Duloxetine, Bupropion, Gabapentin, Cymbalta, and Buspar. There is no mention of MAOIs in the patient's medication list. However, Duloxetine and Cymbalta are SNRIs and Bupropion is an antidepressant, which may interact with Buspar.

  • The patient requests an increase in Buspar for anxiety.
  • There is a potential risk of serotonin syndrome when using Buspar with other serotonergic drugs, including SNRIs and SSRIs.
  • Given the patient's current medication regimen, it is recommended to exercise caution when increasing the dose of Buspar 2, 2.
  • A conservative approach would be to monitor the patient closely for signs of serotonin syndrome and adjust the dose of Buspar accordingly.

From the Research

Patient's Current Condition

The patient is a 56-year-old female with a history of anxiety, gourd, and depression. She reports feeling better overall but has experienced a slight increase in anxiety due to life situations.

Medications

The patient is currently taking the following medications:

  • Duloxetine (Cymbalta)
  • Bupropion
  • Gabapentin
  • Buspar (patient requests an increase for anxiety)

Relevant Studies

Studies have shown that duloxetine is effective in the treatment of generalized anxiety disorder (GAD) and major depressive disorder (MDD) 3, 4. Duloxetine has been shown to improve symptoms of anxiety and depression, as well as functional impairment and quality of life.

Treatment Options

The patient's request to increase the dose of Buspar for anxiety can be considered in light of the studies that have shown the efficacy of duloxetine in treating GAD 3. Additionally, the use of cognitive-behavioral therapy (CBT) in combination with medication has been shown to be effective in treating GAD 5.

Medication Adherence

Medication adherence is an important aspect of treatment, and studies have shown that non-adherence can have significant consequences 6, 7. Strategies to improve medication adherence, such as patient education, medication regimen management, and reminders, can be implemented to support the patient's treatment plan.

Key Points

  • Duloxetine is effective in treating GAD and MDD
  • CBT in combination with medication can be effective in treating GAD
  • Medication adherence is crucial for successful treatment
  • Strategies to improve medication adherence can be implemented to support the patient's treatment plan
  • The patient's request to increase the dose of Buspar for anxiety can be considered in light of the available evidence 3, 4, 5

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

6
Research

Medication adherence: understanding the issues and finding solutions.

British journal of community nursing, 2020

Related Questions

What antihistamine is used for duloxetine (Cymbalta) withdrawal symptoms?
What should a patient taking duloxetine (Cymbalta) 30mg do if they want to increase their dose?
What are the potential add-ons to duloxetine (Cymbarm (duloxetine))?
What is another name for duloxetine?
What's the next step for a patient on duloxetine (cymbalta) 70mg/day with fluctuating depression and controlled anxiety?
What is the role of Bisphosphonates (bone resorption inhibitors) in preventing fractures?
What are the potential complications of a periorbital hematoma (contusion) to a toddler's eyelid?
Is the patient experiencing lithium toxicity, given their increased dosage to 750 milligrams (mg) twice daily, resulting in symptoms of lethargy, decreased motivation, and difficulty speaking, despite improved hallucinations and anxiety while taking lithium and previously taking Lurasidone (lurasidone hydrochloride)?
What are the diagnostic criteria for Evan's syndrome (Evans syndrome), a disorder characterized by the combination of autoimmune hemolytic anemia (AIHA) and immune thrombocytopenic purpura (ITP)?
What antibiotics are recommended for a contaminated puncture wound?
What is the differential diagnosis for a 73-year-old female presenting with a dry cough, a negative D-dimer (Deep Vein Thrombosis marker) test, and a cough that causes a tickling sensation in the throat?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question